Specialized Dermatological Treatment Options with Imiquimod - Softcover

Imiquimod belongs to the class of topical immune response modifiers. It influences both the innate and acquired immune defense systems through stimulation of Toll-like receptor 7. With its antiviral and antineoplastic action, imiquimod cream alters local immunity in the skin in the area of application.
Imiquimod cream has been approved for the treatment of condylomata acuminata, superficial basal cell carcinoma, and actinic keratoses. This volume provides a clear description of these clinical pictures, as well as numerous new off-label indications.